Frontlight ResearchEarly access
What researchers published on Acute lymphoblastic leukaemia
2,166 papers, newest first.
Showing 20 of 80
Trial resultIndividualizing Apheresis Processing Volumes Using a Predictive Algorithm: Analysis of the CAR T-Cell Collection Protocol Utilized in ACIT001/EXC002, a Phase Ib/II Trial of Decentralized Production of CAR T Cells for Treatment of Relapsed/Refractory Aggressive NHL and ALL.Journal of clinical apheresis
In plain wordsRead moreRead the paper on PubMedTrial resultEx Vivo Thrombin Generation Assessment of Four Anticoagulants in Children with Acute Lymphoblastic Leukemia.Pediatric hematology and oncology
In plain wordsRead moreRead the paper on PubMedTrial resultA Mobile Health Intervention to Reduce Sedentary Behavior Among Adolescents and Early Young Adults Receiving Treatment for Acute Lymphoblastic Leukemia: Protocol for a Single-Arm Feasibility Trial.JMIR research protocols
Trial resultTranscriptome Analysis Identifies a Myeloid-Like Signature in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Patients With Poor Response to CD19 Chimeric Antigen Receptor T Cell Therapy.Cancer medicine
In plain wordsRead moreRead the paper on PubMedRandomised trialPonatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.The New England journal of medicine
In plain wordsRead moreRead the paper on PubMedRandomised trialAdverse Family Outcomes in Children With B-Cell Acute Lymphoblastic Leukemia From the Multicenter Trial Children's Oncology Group AALL0932.Journal of the National Comprehensive Cancer Network : JNCCN
In plain wordsRead moreRead the paper on PubMedTrial resultRapid manufactured CAR-T cells enriched for CD45RA-negative T cells exhibit superior persistence compared to conventional CAR-T therapy.Cancer letters
In plain wordsRead moreRead the paper on PubMedRandomised trialBlinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic Leukemia.The New England journal of medicine
In plain wordsRead moreRead the paper on PubMedTrial resultENCERT: A Multisite Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide, and Etoposide in Relapsed T-Cell Lymphoblastic Leukemia/Lymphoma.Pediatric blood & cancer
In plain wordsRead moreRead the paper on PubMedTrial resultClinical and molecular prognostic factors in newly diagnosed pediatric T-cell lymphoblastic lymphoma: a prospective, multicenter, single-arm phase 2 clinical trial.World journal of pediatrics : WJP
In plain wordsRead moreRead the paper on PubMedRandomised trialEffectiveness of oral cryotherapy in preventing methotrexate-induced oral mucositis in pediatric patients with acute lymphoblastic leukemia: a randomized controlled trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
In plain wordsRead moreRead the paper on PubMedTrial resultLong-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
In plain wordsRead moreRead the paper on PubMedTrial resultComparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.Leukemia
In plain wordsRead moreRead the paper on PubMedTrial resultInotuzumab ozogamicin therapy for measurable residual disease in adult acute lymphoblastic leukemia.Blood cancer journal
In plain wordsRead moreRead the paper on PubMedTrial resultCAR T-cell therapy as a definitive consolidation for older adults with B-ALL in first complete remission.Blood advances
In plain wordsRead moreRead the paper on PubMedRandomised trialComparative assessment of asparaginase activity, population pharmacokinetics, and safety of biosimilar native Escherichia coli and pegylated asparaginase in children with newly diagnosed acute lymphoblastic leukemia: a pharmacometrics-based randomized clinical trial.BMC cancer
In plain wordsRead moreRead the paper on PubMedTrial resultInotuzumab ozogamicin in paediatric very high risk first B-cell acute lymphoblastic leukaemia relapse (ITCC-059): a multicentre, single-arm, phase 2 trial.The Lancet. Haematology
In plain wordsRead moreRead the paper on PubMedTrial resultCD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results.Journal for immunotherapy of cancer
In plain wordsRead moreRead the paper on PubMedTrial resultCAR T-cell Kinetics, Persistence, and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-cell ALL Treated with Obecabtagene Autoleucel in the FELIX Study.Cancer research communications
In plain wordsRead moreRead the paper on PubMedTrial resultNon-gene-edited, CD19-targeted, allogeneic CAR-T cell therapy for relapsed or refractory B-cell acute lymphoblastic leukemia: an open-label, single-arm phase 1 study.Bone marrow transplantation
In plain wordsRead moreRead the paper on PubMed